Postcoital test abnormalities in relation to contraceptive use.

Int J Fertil

Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle.

Published: February 1988

Abnormalities of cervical mucus can have a bearing on a woman's fertility. One means of detecting the presence of such abnormalities is the postcoital test (PCT). As part of a population-based case control study of risk factors for infertility, the reproductive, contraceptive, medical, and sexual histories of women seeking treatment for infertility who had abnormal PCT results were compared with those of fertile controls. A greater proportion of infertile women with an abnormal PCT had previously used a diaphragm than had control women (relative risk (RR) = 3.5, 95% CI = 1.1-11.3). The excess risk associated with use of a diaphragm was particularly high for women who had used one for longer than one year (RR = 7.3, 95% CI = 1.4-37.8), or within one year of attempting to conceive (RR = 5.5, 95% CT = 1.4-22.1). No increased risk was associated with the use of other barrier methods, oral contraceptives, or the intrauterine device.

Download full-text PDF

Source

Publication Analysis

Top Keywords

postcoital test
8
abnormal pct
8
risk associated
8
test abnormalities
4
abnormalities relation
4
relation contraceptive
4
contraceptive abnormalities
4
abnormalities cervical
4
cervical mucus
4
mucus bearing
4

Similar Publications

Article Synopsis
  • Emergency contraceptive pills (ECPs) are underutilized in South-Asia, particularly in Pakistan, where the study aimed to assess knowledge and practices regarding ECPs among married individuals in Karachi.
  • The study found that a large majority of participants (85.8%) had low knowledge of ECPs, with only 11.1% having ever used them; barriers included concerns about side effects and religious beliefs.
  • Despite some awareness from counseling, overall ECP usage remains low, highlighting the need for better education and access to family planning resources in the region.
View Article and Find Full Text PDF

A revisit of knowledge, attitude and practice of emergency contraception in Hong Kong.

BMJ Sex Reprod Health

December 2024

The Family Planning Association of Hong Kong, Hong Kong, Hong Kong.

Objectives: To revisit women's knowledge, attitudes and practices (KAP) regarding emergency contraception (EC) in Hong Kong. The research sought to provide insights for improving the accessibility and quality of EC services.

Study Design: A cross-sectional study, where self-administered questionnaires were distributed at a major community sexual and reproductive health service in Hong Kong over a 3-month period between July 2023 and October 2023.

View Article and Find Full Text PDF

Objective: To determine whether increasing the dose of ulipristal acetate (UPA)-containing emergency contraception (EC) improves pharmacodynamic outcomes in individuals with obesity.

Study Design: We enrolled healthy, regularly-cycling, confirmed ovulatory, reproductive-age individuals with body mass index (BMI) >30 kg/m and weight >80 kg in a randomised crossover study. We monitored participants with transvaginal ultrasound and blood sampling for progesterone, luteinising hormone (LH), and estradiol every other day until a dominant follicle measuring >15 mm was visualised.

View Article and Find Full Text PDF

Maximizing the effectiveness of 1.5 mg levonorgestrel for emergency contraception: The case for precoital use.

Contracept X

May 2024

FHI 360, Product Development and Introduction Department, Durham, NC, United States.

Objectives: U.S. and World Health Organization Selected Practice Recommendations for Contraceptive Use state people may have an advanced supply of emergency contraception (EC) to minimize treatment delays.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!